EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Limosilactobacillus reuteri ameliorates diet-associated metabolic dysfunction in PCOS-like rats: associations with intestinal lipid remodeling and GPR120-related regulation

Cong Wang, Shang Li, Junyu Zhai, Juanjuan Yu, Xiying Zhou, Kewei Wu, Yuliu Xu, Meiyi He, Lexin Yang, Min Hou, Zi-Jiang Chen, Yanzhi Du

Frontiers in Nutrition · 03.11.2026 · 13

DOI: 10.3389/fnut.2026.1952526 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Nutrition, online erschienen am 03.11.2026. Verfasst von Cong Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Reproductive Medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Polycystic ovary syndrome (PCOS) is a common endocrine-metabolic disorder frequently accompanied by dyslipidemia. However, the relationships among Limosilactobacillus reuteri ( L. reuteri ) supplementation, gut microbiota-associated lipid remodeling, and PCOS-related metabolic dysfunction remain unclear.

Methods

A high-fat diet combined with dehydroepiandrosterone-induced PCOS-like rat model (HFHA) was established to evaluate the effects of L. reuteri supplementation. Gut microbiota composition, lipidomic profiles, jejunal GPR120/PPARγ-related molecular markers, and fatty-acid transporter expression were assessed. Potential GPR120-associated involvement was pharmacologically evaluated using AH-7614, with complementary experiments performed in Caco-2 cells.

Results

L. reuteri alleviated high-fat diet-associated metabolic dysfunction, reducing body-weight gain, dyslipidemia, and hepatic steatosis. Formal interaction analyses further supported metabolic-context-dependent effects for several metabolic and endocrine endpoints. L. reuteri supplementation altered gut microbial composition and was associated with increased abundances of colonic fatty-acid features putatively annotated as FA(22:5), FA(24:5), and FA(24:6). These colonic lipid-profile changes occurred alongside increased jejunal GPR120 expression, reduced PPARγ abundance, and lower CD36/FABP2 expression. AH-7614 co-treatment attenuated several metabolic, reproductive, and intestinal effects associated with L. reuteri supplementation. In Caco-2 cells, pharmacological modulation or overexpression of GPR120 reduced FFA-induced CD36 and FABP2 expression and intracellular lipid accumulation, whereas AH-7614 or Barbadin treatment attenuated these responses.

Conclusion

L. reuteri improves diet-associated metabolic dysfunction in PCOS-like rats, accompanied by gut microbiota remodeling, altered intestinal lipid profiles, reduced intestinal lipid accumulation, and GPR120-associated regulation of CD36 and FABP2. These findings support a potential role for altered intestinal lipid handling in the metabolic effects of L. reuteri , although the identities, origins, and direct receptor activities of the relevant lipid mediators require further investigation.

Schlagwörter

Stichwörter der Autor:innen

CD36GPR120Limosilactobacillus reuteripolycystic ovary syndromepolyunsaturated fatty acids

Autor:innen und Institutionen

  • Department of Reproductive Medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai, China.
  • State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan, Shandong, China.
  • National Research Center for Assisted Reproductive Technology and Reproductive Genetics, Shandong University, Jinan, Shandong, China.

Zitieren

APA

Wang, C., Li, S., Zhai, J., Yu, J., Zhou, X., Wu, K., Xu, Y., He, M., Yang, L., Hou, M., Chen, Z. J., & Du, Y. (2026). Limosilactobacillus reuteri ameliorates diet-associated metabolic dysfunction in PCOS-like rats: associations with intestinal lipid remodeling and GPR120-related regulation. Frontiers in Nutrition, 13. https://doi.org/10.3389/fnut.2026.1952526

Vancouver

Wang C, Li S, Zhai J, Yu J, Zhou X, Wu K, et al. Limosilactobacillus reuteri ameliorates diet-associated metabolic dysfunction in PCOS-like rats: associations with intestinal lipid remodeling and GPR120-related regulation. Frontiers in Nutrition. 2026;13. doi:10.3389/fnut.2026.1952526

BibTeX
@article{Wang2026,
  author = {Wang, Cong and Li, Shang and Zhai, Junyu and Yu, Juanjuan and Zhou, Xiying and Wu, Kewei and Xu, Yuliu and He, Meiyi and Yang, Lexin and Hou, Min and Chen, Zi-Jiang and Du, Yanzhi},
  title = {Limosilactobacillus reuteri ameliorates diet-associated metabolic dysfunction in PCOS-like rats: associations with intestinal lipid remodeling and GPR120-related regulation},
  journal = {Frontiers in Nutrition},
  year = {2026},
  volume = {13},
  doi = {10.3389/fnut.2026.1952526}
}
Kostenlos starten →